dxlink
Accredited Programs
  • Home
  • Real-world Evidence for Oral Anticoagulation
    Dr. Gregory Lip (30 minutes)
  • Stroke Prevention in Atrial Fibrillation Patients with CAD/ACS/PCI
    Dr. L. Brent Mitchell (19 minutes)
  • Complex Case for Stroke Prevention in AF
    Dr. Paul Dorian (15 minutes)
  • Discussion Forum
  • Program Evaluation
  • Accreditation
Herpes Zoster banner
Presenters
Gregory YH Lip, MD, FRCP, DFM, FACC, FESC
Professor of Cardiovascular Medicine, University of Birmingham, UK;
Adjunct Professor of Cardiovascular Sciences, Thrombosis Research Unit, Aalborg University, Denmark;
Visiting Professor of Haemostasis Thrombosis & Vascular Sciences, Aston University, Birmingham, UK;
Visiting Professor of Cardiology, University of Belgrade, Serbia
L. Brent Mitchell, MD, FRCPC
Professor, Department of Cardiac Sciences
Calgary Zone, Alberta Health Services and
Libin Cardiovascular Institute of Alberta
Calgary, Alberta, Canada
Paul Dorian MD, MSc, FRCP(C)
Dexter H.C. Man Chair in Cardiology
Department Director, Division of Cardiology
Staff Cardiac Electrophysiologist
St. Michael’s Hospital
Professor of Medicine
Division of Cardiology and
Division of Clinical Pharmacology
University of Toronto
Toronto, Ontario
Learning Objectives

At the end of this session, participants will be able to:
  • Integrate recent data from randomized trials and national and international databases and registries on the real-world use, effectiveness and safety of oral anticoagulants in patients with AF.
  • Consider additional treatment scenarios such as AF with concomitant coronary artery disease and recognize the role of various antithrombotic agents for stroke prevention in such settings.
  • Individualize antithrombotic therapy and practice effective DOAC usage in patients with special considerations, whilst balancing risk of bleeding with the benefit of stroke prevention.
Accreditation

This event is an accredited group learning activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program. It is approved by the Canadian Cardiovascular Society for a maximum of 1.5 credits. This accredited symposium is co-developed with the Canadian Cardiovascular Society and BMS / Pfizer Alliance and is planned to ensure the evidence presented is valid, objective and balanced.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 CreditsTM
The information and opinions contained herein reflect the views and experience of the authors and not necessarily those of the sponsors or STA Communications Inc. It is recommended that physicians evaluate their patient’s individual conditions before making a diagnosis or treatment decision. Any products mentioned herein should be used in accordance with the prescribing information contained in their respective product monographs. The content on this site is intended for health professionals. Copyright 2016 STA Communications Inc. All rights reserved. Content on this site may not be reproduced without explicit consent from the sponsor and STA Communications Inc. Terms and Conditions | Privacy Policy